Loading...
Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients
BACKGROUND: We report the safety and efficacy of eribulin as a late treatment line in Thai metastatic breast cancer (MBC) patients. PATIENTS AND METHODS: A total of 30 MBC patients treated with eribulin between January 2014 and January 2017 were retrospectively analyzed. The patients were scheduled...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6074808/ https://ncbi.nlm.nih.gov/pubmed/30104885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S166399 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|